Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Raby

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2025
A national framework for moving towards more environmentally sustainable radiotherapy: the green radiotherapy frameworkSara Lightowlers, Sophie Raby, Robert Chuter, et al.
BMJ (Clinical Research Ed.)|February 14, 2013
An unexpected finding after a fall from a horseSophie Raby, Daniel Greaves, Joseph Padayatty, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Acute presentations in neoadjuvant chemotherapy/immune checkpoint inhibition for triple negative breast cancer: experiences and impact from real-world dataTim Cooksley, Safwaan Adam, Bence Nagy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2023
Low muscle mass measured at T12 is a prognostic biomarker in unresectable oesophageal cancers receiving chemoradiotherapyDónal Michael McSweeney, Sophie Raby, Ganesh Radhakrishna, et al.
Clinical Breast Cancer|January 9, 2025
Development and Evaluation of a Remote Monitoring Regional Adjuvant Abemaciclib Service for Patients With High-Risk Early Breast CancerNicole L Brown, Ann Tivey, Suzanne Frank, et al.
Oncoimmunology|June 19, 2023
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1Debayan Mukherjee, Erminia Romano, Richard Walshaw, et al.
Therapeutic Advances in Medical Oncology|March 10, 2023
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapyPaula Jimenez-Fonseca, Victoria Foy, Sophie Raby, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2025
A national framework for moving towards more environmentally sustainable radiotherapy: the green radiotherapy frameworkSara Lightowlers, Sophie Raby, Robert Chuter, et al.
BMJ (Clinical Research Ed.)|February 14, 2013
An unexpected finding after a fall from a horseSophie Raby, Daniel Greaves, Joseph Padayatty, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Acute presentations in neoadjuvant chemotherapy/immune checkpoint inhibition for triple negative breast cancer: experiences and impact from real-world dataTim Cooksley, Safwaan Adam, Bence Nagy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2023
Low muscle mass measured at T12 is a prognostic biomarker in unresectable oesophageal cancers receiving chemoradiotherapyDónal Michael McSweeney, Sophie Raby, Ganesh Radhakrishna, et al.
Clinical Breast Cancer|January 9, 2025
Development and Evaluation of a Remote Monitoring Regional Adjuvant Abemaciclib Service for Patients With High-Risk Early Breast CancerNicole L Brown, Ann Tivey, Suzanne Frank, et al.
Oncoimmunology|June 19, 2023
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1Debayan Mukherjee, Erminia Romano, Richard Walshaw, et al.
Therapeutic Advances in Medical Oncology|March 10, 2023
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapyPaula Jimenez-Fonseca, Victoria Foy, Sophie Raby, et al.
Pageof 1